Home › NDC Lookup › RxCUI directory › RxCUI 198412

500 ML tromethamine 36 MG/ML Injection — RxCUI 198412

RxNorm drug concept · Semantic clinical drug
RxCUI 198412 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI198412
Official name500 ML tromethamine 36 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known astromethamine 18 GM per 500 ML Injection; THAM 36 MG/ML in 500 ML Injection; tromethamine 3.6 GM per 100 ML Injection
FDA products mapped3
Package NDCs mapped3
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How 500 ML tromethamine 36 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 500 ML tromethamine 36 MG/ML Injection RxCUI 198412

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Tromethamine 10865
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Tromethamine Injection 1868504
    • Tromethamine Injectable Product 1159357
    • Injection 1649574
    • Injectable Product 1151126
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Tromethamine 36 MG/ML 328769

Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Tromethamine 36 MG/ML SCDC · 328769
  • Tromethamine Injection SCDF · 1868504
  • Tromethamine Injectable Product SCDG · 1159357

📦 FDA Products & Package NDCs

3 products · 3 package NDCs
3 package NDCs map to RxCUI 198412 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00264-8031-10 24 BAG in 1 CASE (0264-8031-10) / 500 mL in 1 BAG TROMETHAMINE B. Braun Medical Inc. 2025-08-27
00409-1593-04 6 BOTTLE, GLASS in 1 CASE (0409-1593-04) / 500 mL in 1 BOTT... THAM Hospira, Inc. 2020-06-24
71357-0001-01 6 BOTTLE, GLASS in 1 CASE (71357-001-01) / 500 mL in 1 BOTT... Tromethamine MILLA PHARMACEUTICALS INC. 2024-12-31
Observed labelers: B. Braun Medical Inc. (1) · Hospira, Inc. (1) · MILLA PHARMACEUTICALS INC. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.